Understanding pharmacokinetics to improve tuberculosis treatment outcome
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Understanding pharmacokinetics to improve tuberculosis treatment outcome
Authors
Keywords
-
Journal
Expert Opinion on Drug Metabolism & Toxicology
Volume 10, Issue 6, Pages 813-823
Publisher
Informa Healthcare
Online
2014-03-06
DOI
10.1517/17425255.2014.895813
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of rifampin-based antituberculosis therapy on plasma efavirenz concentrations in children vary by CYP2B6 genotype
- (2013) Helen M. McIlleron et al. AIDS
- Plasma Drug Activity in Patients on Treatment for Multidrug-Resistant Tuberculosis
- (2013) Stellah G. Mpagama et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Sensititre MYCOTB MIC Plate for Testing Mycobacterium tuberculosis Susceptibility to First- and Second-Line Drugs
- (2013) Jongseok Lee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Application of quantitative second-line drug susceptibility testing at a multidrug-resistant tuberculosis hospital in Tanzania
- (2013) Stellah G Mpagama et al. BMC INFECTIOUS DISEASES
- A multi-arm multi-stage clinical trial design for binary outcomes with application to tuberculosis
- (2013) Daniel J Bratton et al. BMC Medical Research Methodology
- Costs of tuberculosis disease in the European Union: a systematic analysis and cost calculation
- (2013) R. Diel et al. EUROPEAN RESPIRATORY JOURNAL
- Therapeutic drug management: is it the future of multidrug-resistant tuberculosis treatment?
- (2013) Shashikant Srivastava et al. EUROPEAN RESPIRATORY JOURNAL
- Drug concentration in lung tissue in multidrug-resistant tuberculosis
- (2013) Onno W. Akkerman et al. EUROPEAN RESPIRATORY JOURNAL
- Age, nutritional status and INH acetylator status affect pharmacokinetics of anti-tuberculosis drugs in children
- (2013) G. Ramachandran et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Serum Drug Concentrations Predictive of Pulmonary Tuberculosis Outcomes
- (2013) J. G. Pasipanodya et al. JOURNAL OF INFECTIOUS DISEASES
- Universal access to care for multidrug-resistant tuberculosis: an analysis of surveillance data
- (2013) Dennis Falzon et al. LANCET INFECTIOUS DISEASES
- Tuberculosis biomarkers discovery: developments, needs, and challenges
- (2013) Robert S Wallis et al. LANCET INFECTIOUS DISEASES
- Indolcarboxamide Is a Preclinical Candidate for Treating Multidrug-Resistant Tuberculosis
- (2013) S. P. S. Rao et al. Science Translational Medicine
- Population Pharmacokinetics and Pharmacodynamics of Ofloxacin in South African Patients with Multidrug-Resistant Tuberculosis
- (2012) Emmanuel Chigutsa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Dried Blood Spot Analysis for Therapeutic Drug Monitoring of Linezolid in Patients with Multidrug-Resistant Tuberculosis
- (2012) D. H. Vu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Retooling Existing Tuberculosis Drugs for Children
- (2012) J. A. Seddon et al. CLINICAL INFECTIOUS DISEASES
- The future of molecular diagnostics for drug-resistant tuberculosis
- (2012) Scott K Heysell et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Evaluation of the Sensititre MycoTB Plate for Susceptibility Testing of the Mycobacterium tuberculosis Complex against First- and Second-Line Agents
- (2012) L. Hall et al. JOURNAL OF CLINICAL MICROBIOLOGY
- PanACEA: a new approach to tuberculosis research
- (2012) Talha Burki LANCET INFECTIOUS DISEASES
- Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial
- (2012) Rovina Ruslami et al. LANCET INFECTIOUS DISEASES
- Linezolid for Treatment of Chronic Extensively Drug-Resistant Tuberculosis
- (2012) Myungsun Lee et al. NEW ENGLAND JOURNAL OF MEDICINE
- Plasma Drug Activity Assay for Treatment Optimization in Tuberculosis Patients
- (2011) Scott K. Heysell et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Protease inhibitor-containing antiretroviral treatment and tuberculosis: can rifabutin fill the breach? [Review article]
- (2011) A. Loeliger et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Multidrug-Resistant Tuberculosis Not Due to Noncompliance but to Between-Patient Pharmacokinetic Variability
- (2011) Shashikant Srivastava et al. JOURNAL OF INFECTIOUS DISEASES
- Integration of Antiretroviral Therapy with Tuberculosis Treatment
- (2011) Salim S. Abdool Karim et al. NEW ENGLAND JOURNAL OF MEDICINE
- Earlier versus Later Start of Antiretroviral Therapy in HIV-Infected Adults with Tuberculosis
- (2011) François-Xavier Blanc et al. NEW ENGLAND JOURNAL OF MEDICINE
- Timing of Antiretroviral Therapy for HIV-1 Infection and Tuberculosis
- (2011) Diane V. Havlir et al. NEW ENGLAND JOURNAL OF MEDICINE
- Short, Highly Effective, and Inexpensive Standardized Treatment of Multidrug-resistant Tuberculosis
- (2010) Armand Van Deun et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- An Oracle: Antituberculosis Pharmacokinetics-Pharmacodynamics, Clinical Correlation, and Clinical Trial Simulations To Predict the Future
- (2010) Jotam Pasipanodya et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Treatment Outcomes among Patients with Extensively Drug‐Resistant Tuberculosis: Systematic Review and Meta‐Analysis
- (2010) Karen R. Jacobson et al. CLINICAL INFECTIOUS DISEASES
- Pharmacokinetics and Whole‐Blood Bactericidal Activity againstMycobacterium tuberculosisof Single Doses of PNU‐100480 in Healthy Volunteers
- (2010) Robert S. Wallis et al. JOURNAL OF INFECTIOUS DISEASES
- Efflux‐Pump–Derived Multiple Drug Resistance to Ethambutol Monotherapy inMycobacterium tuberculosisand the Pharmacokinetics and Pharmacodynamics of Ethambutol
- (2010) Shashikant Srivastava et al. JOURNAL OF INFECTIOUS DISEASES
- Timing of Initiation of Antiretroviral Drugs during Tuberculosis Therapy
- (2010) Salim S. Abdool Karim et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cerebrospinal fluid concentrations of antituberculosis agents in adults and children
- (2010) P.R. Donald TUBERCULOSIS
- Update on Rifampin and Rifabutin Drug Interactions
- (2009) Anne M. Baciewicz et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- Pharmacokinetics-Pharmacodynamics of Pyrazinamide in a Novel In Vitro Model of Tuberculosis for Sterilizing Effect: a Paradigm for Faster Assessment of New Antituberculosis Drugs
- (2009) T. Gumbo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Rifampin pharmacokinetics in children, with and without human immunodeficiency virus infection, hospitalized for the management of severe forms of tuberculosis
- (2009) Hendrik Simon Schaaf et al. BMC Medicine
- A Randomized Trial Comparing Plasma Drug Concentrations and Efficacies between 2 Nonnucleoside Reverse‐Transcriptase Inhibitor–Based Regimens in HIV‐Infected Patients Receiving Rifampicin: The N2R Study
- (2009) Weerawat Manosuthi et al. CLINICAL INFECTIOUS DISEASES
- Isoniazid Plasma Concentrations in a Cohort of South African Children with Tuberculosis: Implications for International Pediatric Dosing Guidelines
- (2009) Helen McIlleron et al. CLINICAL INFECTIOUS DISEASES
- Isoniazid, Rifampin, Ethambutol, and Pyrazinamide Pharmacokinetics and Treatment Outcomes among a Predominantly HIV‐Infected Cohort of Adults with Tuberculosis from Botswana
- (2009) Sekai Chideya et al. CLINICAL INFECTIOUS DISEASES
- Association of high T allele frequency of CYP2B6 G516T polymorphism among ethnic south Indian HIV-infected patients with elevated plasma efavirenz and nevirapine
- (2009) G. Ramachandran et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Tuberculosis and diabetes mellitus: convergence of two epidemics
- (2009) Kelly E Dooley et al. LANCET INFECTIOUS DISEASES
- Treatment of Active Pulmonary Tuberculosis in Adults: Current Standards and Recent Advances
- (2009) Ronald G Hall et al. PHARMACOTHERAPY
- Dried Blood Spot Methods in Therapeutic Drug Monitoring: Methods, Assays, and Pitfalls
- (2009) Peter M Edelbroek et al. THERAPEUTIC DRUG MONITORING
- Early and Extended Early Bactericidal Activity of Linezolid in Pulmonary Tuberculosis
- (2008) Reynaldo Dietze et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Early Bactericidal Activity and Pharmacokinetics of the Diarylquinoline TMC207 in Treatment of Pulmonary Tuberculosis
- (2008) R. Rustomjee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multidrug-resistant and extensively drug-resistant tuberculosis: consequences for the global HIV community
- (2008) Sheela Shenoi et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Peak plasma rifampicin level in tuberculosis patients with slow culture conversion
- (2008) K.-C. Chang et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Outcomes of Nevirapine- and Efavirenz-Based Antiretroviral Therapy When Coadministered With Rifampicin-Based Antitubercular Therapy
- (2008) Andrew Boulle JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Diabetes Mellitus Increases the Risk of Active Tuberculosis: A Systematic Review of 13 Observational Studies
- (2008) Christie Y Jeon et al. PLOS MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started